Dihydroergotamine Completed Phase 1 Trials for Migraine With Aura / Migraine Without Aura / Migraine Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT03874832A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
NCT03401346Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults